Levitra of benefit to diabetic men

Pharma Marketletter, June, 2004

Unlike the global erectile dysfunction drug market leader, Pfizer's Viagra (sildenafil), Bayer/GlaxoSmithKline's Levitra (vardenafil) appears to be of benefit to diabetic men, according to the results of studies presented at the American Diabetes Association in Orlando, Florida, a factor which could help the latter firms in their fight for market share of the huge ED market; Viagra's annual sales are in the region of $2 billion.

Men being treated for diabetes are three times more likely to have ED than those in the general population. In addition, more than 50% of diabetic men develop ED within 10 years of being diagnosed with diabetes, and the condition tends to be difficult to treat in diabetic men, notes a Bayer/GSK press statement.

Study results showed...

Premium Content Partnership
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement